Other than making me swallow humble pie and retire my crystal ball, what does it mean for medical research an institutions such as Peter MacCallum? One early response I got when I asked the question was "the $20B is very welcome news for the sector and visionary in many ways as Australia plans for a post-resource boom economy. The money will gradually increase over the next 3-4 years and no doubt be very good news for Peter Mac, as Australia's leading cancer research group. However substantial funding is 4 years away (if its gets through the senate) and patients need advances now!"
One article written by Dan Harrison of the Sydney Morning Herald (online http://www.smh.com.au/national/new-20-billion-medical-research-fund-wonky-wedge-or-wonder-cure-20140517-38gss.html#ixzz32QnQpi94) gave some further consideration. While details are still being worked out, key take home messages seem to be:
- The money wouldn't be available immediately - the fund needs to grow up to $20bn and that isn't expected until 2020 and then the distribution made available is the interest on the capital, which would mean something like $500m in 2020 and $1bn in 2022.
- The distribution will be across a number of priority health priority areas (arthritis, asthma, cancer, cardiovascular disease, dementia, diabetes, injury, mental health and obesity).
- It still needs approval and is being tied to the less politically palatable cost co-payments initiatives (such as the $7 fee for GP visits)
So nothing is certain yet, other than the fact that there is research that needs funding right now, and that events such as the ride to conquer cancer will still have a very important place in allowing Peter MacCallum the capacity and discretion to fund their medical research.